Sébastien Thureau Selected Research

Sébastien Thureau Research Topics

10	Neoplasms (Cancer) 03/2023 - 09/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 02/2015
6	Hypoxia (Hypoxemia) 03/2023 - 06/2018
5	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 06/2018
5	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2013
4	Neoplasm Metastasis (Metastasis) 02/2021 - 08/2008
3	Inflammatory Breast Neoplasms 04/2024 - 08/2022
3	Squamous Cell Carcinoma of Head and Neck 02/2021 - 01/2017
2	Xerostomia 02/2024 - 01/2023
2	Oropharyngeal Neoplasms 03/2023 - 01/2023
2	Sarcopenia 02/2021 - 05/2020
1	Thymoma (Thymic Carcinoma) 04/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2024
1	Breast Neoplasms (Breast Cancer) 02/2021
1	COVID-19 06/2020
1	Prostatic Neoplasms (Prostate Cancer) 06/2018
1	Esophageal Squamous Cell Carcinoma 06/2015
1	Esophageal Neoplasms (Esophageal Cancer) 06/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2008

7	fluoromisonidazoleIBA 03/2023 - 09/2013
3	fluoroazomycin arabinosideIBA 01/2023 - 05/2020
2	ParaffinIBA 02/2024 - 01/2023
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018 - 02/2015
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	FluorineIBA 08/2021
1	MisonidazoleIBA 08/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 02/2019
1	PlatinumIBA 02/2019
1	Cetuximab (Erbitux)FDA Link 02/2019
1	NivolumabIBA 01/2019
1	fluoromethylcholineIBA 06/2018
1	Carcinoembryonic AntigenIBA 08/2008

22	Radiotherapy 04/2024 - 11/2013
6	Chemoradiotherapy 01/2023 - 02/2015
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2024 - 10/2018
3	Drug Therapy (Chemotherapy) 02/2019 - 08/2008
1	Neoadjuvant Therapy 08/2022
1	Aftercare (After-Treatment) 01/2022
1	Nutritional Support (Artificial Feeding) 02/2021
1	Salvage Therapy 06/2018
1	Palliative Care (Palliative Therapy) 06/2018